laughing couple

The Future of Diagnostics Now.

At Metabolomic Technologies, we are committed to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs.

Learn More

0

Unique Powerful Platform.

There are more than 40,000 small molecule metabolites in the human body. Through the identification of distinct, metabolic fingerprints, we are developing groundbreaking diagnostics.

See our products

A message from our CEO

The strength of our company is in our proprietary technology and our award-winning leadership team. We are focused on bringing our simple, effective solution to market to help manage the disease of colorectal cancer.

Milestone Timeline

2014

1000-Patient Discovery Trial Completed

2016

Validation Trials Completed

2017

2M CAD Seed Round

2017

PolypDx™ LDT Launched

2018

Canadian Assessment of PolypDx™

2018

2018 Economic Model showing PolypDx™ is cost-effective

2019

US Patent Issued - Completing global IP coverage

2019

Discovery & Validation on additional CRC markers

2019

Closed 3.2M USD Series A Round

Haili Wang AsTech Award 7

7 awards in 7 years

We are proud to share the recognition that we've received from people who know a good thing when they see it.

View All Awards

Our Partners

View All
Met some great students at the University of Alberta today. #AIMSS2020Symposium https://t.co/1lCrLYLH02

Interested in partnering with us?

Contact Us